Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT N-of-1 trial for agitation in dementia
2024-510601-29-00Phase 4Authorised
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Dementia comparing Quetiapine N-of-1 sequence, Olanzapine N-of-1 sequence and Lorazepam N-of-1 sequence (3 arms). Planned start Jul 2025; status: authorised.
02
Drugs
lorazepamolanzapinequetiapine
03
Conditions
Dementia
Beyond the preview
Go deeper on 2024-510601-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510601-29-00.